1. Home
  2. ALRS vs ZVRA Comparison

ALRS vs ZVRA Comparison

Compare ALRS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alerus Financial Corporation

ALRS

Alerus Financial Corporation

N/A

Current Price

$31.71

Market Cap

831.8M

Sector

Finance

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$10.30

Market Cap

689.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALRS
ZVRA
Founded
1879
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
831.8M
689.4M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
ALRS
ZVRA
Price
$31.71
$10.30
Analyst Decision
Hold
Strong Buy
Analyst Count
5
9
Target Price
★ $35.40
$25.00
AVG Volume (30 Days)
121.5K
★ 746.1K
Earning Date
10-29-2026
11-04-2026
Dividend Yield
★ 2.79%
N/A
EPS Growth
N/A
★ 159.21
EPS
★ 1.70
0.74
Revenue
N/A
★ $106,470,000.00
Revenue This Year
$5.94
$42.97
Revenue Next Year
$2.67
$16.27
P/E Ratio
$18.65
★ $15.19
Revenue Growth
N/A
★ 350.91
52 Week Low
$20.31
$8.01
52 Week High
$34.40
$15.04

Technical Indicators

Market Signals
Indicator
ALRS
ZVRA
Relative Strength Index (RSI) 32.82 35.04
Support Level $30.13 $10.18
Resistance Level $31.86 $11.07
Average True Range (ATR) 0.67 0.38
MACD -0.15 -0.11
Stochastic Oscillator 0.00 0.32

Price Performance

Historical Comparison
ALRS
ZVRA

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and others. The company provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services and wealth management services, including retirement plans, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: